No products in the cart.
Ursodeoxycholic Acid Tablets (Bifu) – 0.25?g × 18 Tablets
$1.00
Bifu Ursodeoxycholic Acid Tablets contain 250?mg of UDCA per tablet in an 18?tablet pack (three 6?count blisters). Produced by Wuhan Puyuan Pharmaceutical Co., Ltd., under NMPA approval H20123209, this bile acid compound is commonly used in lab models for hepatoprotection, cholestasis, gallstone dissolution, and cholesterol metabolism studies. ?? Strictly for laboratory and research use only.?Please consult staff for other specifications and uses?
Description
Ursodeoxycholic Acid (UDCA), a hydrophilic secondary bile acid, is valued in experimental pharmacology for its cytoprotective, choleretic, and immunomodulatory effects . UDCA reduces cholesterol saturation in bile, stimulates bile acid flow, and replaces hepatotoxic bile acids, making it crucial in models of primary biliary cholangitis, gallstones, and liver dysfunction.
The Bifu brand tablet allows easy oral dosing in preclinical and translational studies involving cholestasis, NAFLD, bile flow regulation, and bile acid receptor (FXR) pathways . Produced by Wuhan Puyuan Pharmaceutical Co., Ltd., approved under H20123209, making it lab?grade and suitable for bulk orders.
Ursodeoxycholic Acid Tablets Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Ursodeoxycholic Acid Tablets (Bifu) |
| Generic Name | Ursodeoxycholic Acid (UDCA) |
| CAS Number | 128?13?2 |
| Molecular Formula | C??H??O? |
| Molecular Weight | ~392.6?g/mol |
| Strength | 0.25?g (250?mg) per tablet |
| Pack Size | 6 tablets × 3 blisters = 18 tablets |
| Dosage Form | Oral tablet |
| Approval Number | H20123209 (NMPA) |
| Manufacturer | Wuhan Puyuan Pharmaceutical Co., Ltd. |
| Barcode | 6971557190008 |
| Storage Conditions | Store ??25?°C, away from light and moisture |
| Intended Use | Laboratory research: cholestasis, hepatoprotection, gallstone studies |
Ursodeoxycholic Acid Tablets Mechanism of Action
UDCA works by:
Displacing hydrophobic bile acids and increasing bile hydrophilicity
Stimulating bile flow via enhanced cholangiocyte secretion
Protecting hepatocytes and cholangiocytes from oxidative stress and apoptosis
Modulating immune response and via FXR receptor activity
Ursodeoxycholic Acid Tablets Research Applications
Primary biliary cholangitis & cholestasis models
Gallstone dissolution and cholesterol metabolism assays
Non?alcoholic fatty liver disease (NAFLD) and oxidative stress studies
Bile flow and FXR pathway research
Hepatocyte cytoprotection and inflammation assays
Ursodeoxycholic Acid Tablets Safety & Handling
Popular in clinical models; low side?effect profile: mild GI upset or paresthesia possible
Lab handling: wear gloves, store out of sunlight
Shelf life: 24–36 months in recommended conditions
Core Keywords
Ursodeoxycholic acid tablets, UDCA 250?mg, CAS 128-13-2, Bifu UDCA tablets, hepatoprotective bile acid, gallstone dissolution research, cholestasis lab compound, Wuhan Puyuan UDCA, bile acid research supply, wholesale Ursodiol tablets
Research Use Disclaimer
This product is intended solely for laboratory/experimental research. It is not authorized for clinical, diagnostic, therapeutic or veterinary use. Improper use may carry health or regulatory consequences. Use only per institutional protocols.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 26 × 23 × 26 cm |
Related products
Thymalfasin Injection 1.6?mg (Harbin/Thymosin ??1) – Wholesale price comparison
Harbin Thymalfasin Injection contains 1.6?mg of Thymosin ??1 per vial with included solvent. Manufactured by Harbin Pharmaceutical Group Bioengineering Co., Ltd., and approved under NMPA H20133153. Commonly used for preclinical research in immune modulation, antiviral response, and vaccine adjuvant studies.
?? For laboratory research use only.?Please consult staff for other specifications and uses? $2.00Tenofovir Alafenamide Fumarate Tablets 25?mg (Zhongyan) – Low price wholesale
Zhongyan Tenofovir Alafenamide Fumarate Tablets contain 25?mg of active drug per tablet in a bottle of 30 tablets. Manufactured by Tianjin Institute of Pharmaceutical Research and approved under NMPA H20233581. Ideal for use in hepatitis B research, viral suppression studies, and pharmacokinetic analysis.
?? For laboratory and research use only. ?Please consult staff for other specifications and uses? $2.00Drotaverine Hydrochloride Injection 40?mg (No?Spa )
No?Spa Drotaverine Hydrochloride Injection delivers 40?mg per 2?ml ampoule, with five ampoules per box. Produced by CHINOIN (Hungary) and approved under NMPA HJ20170302. Ideal for laboratory research involving smooth muscle spasm relief in visceral organs and vascular systems.
?? For laboratory and research use only. ?Please consult staff for other specifications and uses? $1.00N?Acetylcysteine Injection 4?g (Minsheng / Asixintai)
Minsheng (Asixintai) N?Acetylcysteine Injection delivers 4?g per 20?ml vial in a sterile solution. Manufactured by Hangzhou Minsheng Pharmaceutical Co., Ltd., approved under NMPA H20051788. Widely used in preclinical research for hepatoprotective, antioxidant, and mucolytic applications.
?? For laboratory and research use only.?Please consult staff for other specifications and uses? $1.00
Reviews
There are no reviews yet.